Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 373

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 373
---
|:----------------------------------------------------|:--|:--|:-------|:--|----:|:--|:--|
| 2026                                                | ​ | ​ | ​      | ​ | 129 | ​ | ​ |
| 2027                                                | ​ | ​ | ​      | ​ |  88 | ​ | ​ |
| Total lease payments                                | ​ | ​ | ​      | ​ | 281 | ​ | ​ |
| Less: imputed interest                              | ​ | ​ | ​      | ​ | -27 | ​ | ​ |
| Present value of lease liabilities                  | ​ | ​ | ​      | ​ | 254 | ​ | ​ |
| Less: operating lease liabilities, current portion  | ​ | ​ | ​      | $ | 109 | ​ | ​ |
| Operating lease liabilities, net of current portion | ​ | ​ | ​      | $ | 145 | ​ | ​ |

9. Stockholders’ Equity (Deficit) Redeemable Convertible Preferred Stock Prior to the conversion upon the closing of the Merger, Legacy Tvardi issued Series A preferred stock and Series B preferred stock (the Preferred Stock). Prior to the completion of the Merger, Legacy Tvardi classified the Preferred Stock outside of permanent equity as the shares had redemption features that were

F-44

TABLE OF CONTENTS

not entirely within the control of Legacy Tvardi. As discussed in Note 3, Merger Agreement , upon the closing of the Merger, Legacy Tvardi’s Preferred Stock converted into 3,963,910 shares of the Company’s common stock.

Preferred Stock

As of June 30, 2025, the Company had 5,000,000 shares of preferred stock authorized, $0.001 par value, pursuant to its amended and restated certificate of incorporation. However, no such shares were issued or outstanding as of June 30, 2025.

Common Stock

As discussed in Note 3, Merger Agreement , the Company completed its Merger with Cara in April 2025. Upon the closing of the Merger, the following shares of common stock were received by Legacy Tvardi shareholders:

•

Legacy Tvardi common stock converted into 2,575,494 shares of the Company’s common stock in the aggregate.

•

Legacy Tvardi preferred stock converted into 3,963,910 shares of the Company’s common stock in the aggregate.

•

Legacy Tvardi Convertible Notes converted into